Mesothelioma: Our Clinical Trials

Title	Investigator
A Phase I Study of GL-ONC1 for Treating Malignant Pleural Effusion [Protocol 12-169]	Rusch, Valerie, MD
A Phase II Study of WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma [Protocol 10-134]	Krug, Lee, MD
A Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma [Protocol 08-053]	Krug, Lee, MD
A Survey of Psychosocial Needs and Exploration of Online Support for Patients with Pleural Mesothelioma [Protocol 11-066]	Key, Richard, MD

Title

Investigator

Rusch, Valerie, MD

Krug, Lee, MD

Krug, Lee, MD

Key, Richard, MD

Mesothelioma